Comparison of plasma sterilizer and conventional laminar flow room in allogeneic hematopoietic stem cell transplant recipients
Patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT) are typically placed in a laminar air flow room until hematopoietic reconstitution occurs. In this study, we compared the differences in clinical outcomes between patients receiving allo-HSCT in a conventional laminar flow room (<i>n</i> = 200) and those receiving allo-HSCT in a plasma sterilizer environment (<i>n</i> = 201). The overall infection rates (20.4% vs 25.5%, <i>P</i> = 0.224) and the sites of infection (sepsis, perianal infection, and catheter-related infection) were comparable between the two groups. Additionally, the engraftment times were comparable between the two groups in terms of time to allo-HSCT, leukocyte engraftment time, and platelet engraftment time. The 100-day posttransplantation clinical outcomes were also comparable between the two groups in terms of the probability of overall survival (98.5% vs 99.5%, <i>P</i> = 0.316), leukemia-free survival (96.5% vs 96.5%, <i>P</i> = 0.991), the cumulative incidence of relapse (2.0% vs 3.0%, <i>P</i> = 0.523), non-relapse mortality (1.5% vs 0.5%, <i>P</i> = 0.316) and acute graft-versus-host disease (23.4% vs 22.0%, <i>P</i> = 0.723). Thus, our results demonstrated that receiving allo-HSCT via a plasma sterilizer did not increase the risk of pre-engraftment infection, and the clinical outcomes of these patients were comparable to those of patients in a conventional laminar flow room.
Authors
- Jingyu Gao
- Dao-Xing Deng (ORCID: https://orcid.org/0000-0001-8054-614X)
- Xiaohui Zhang (ORCID: https://orcid.org/0000-0002-7938-7134)
- Shanshan Hu (ORCID: https://orcid.org/0000-0002-1316-7892)
- Ling Ma (ORCID: https://orcid.org/0000-0002-3424-3540)
- Wen‐Xuan Huo (ORCID: https://orcid.org/0009-0006-1392-2081)
- Yuqing Xia (ORCID: https://orcid.org/0009-0004-6225-3190)
- Xiao‐Dong Mo (ORCID: https://orcid.org/0000-0002-9881-7945)
- Wenwen Xiao
- Boning Liu
- Yi‐Jie Jia (ORCID: https://orcid.org/0009-0003-8075-0783)
- Jiating Wang
- D. Yao (ORCID: https://orcid.org/0009-0006-8308-5231)
- Yuanyuan Zhang (ORCID: https://orcid.org/0000-0003-4285-2853)
- Jing Liu (ORCID: https://orcid.org/0000-0002-3588-2969)
- Junxia Wang (ORCID: https://orcid.org/0000-0001-8069-8944)
- Wei Hu (ORCID: https://orcid.org/0000-0003-3137-661X)
- Xiao‐Jun Huang (ORCID: https://orcid.org/0000-0002-3636-4813)
- Ce Shi (ORCID: https://orcid.org/0000-0003-0235-8164)
- Yegang Ma (ORCID: https://orcid.org/0000-0002-6973-6177)
- Hao Yin (ORCID: https://orcid.org/0000-0003-4220-811X)
- Xiaoshuang Han
- Qianheng Du (ORCID: https://orcid.org/0000-0002-8117-8489)
- Jun Kong (ORCID: https://orcid.org/0000-0002-9398-8526)
- Yi Xia (ORCID: https://orcid.org/0000-0002-2838-2552)
- Dong Hun Han
- Fengmei Zheng
- Leqing Cao
- Ting Wang (ORCID: https://orcid.org/0009-0003-1256-0750)
Institutions
- Peking University (CN)
- Peking University People's Hospital (CN)
Publication Details
- Journal
- Cell Transplantation
- Published
- 2025-04-30
- DOI
- https://doi.org/10.1177/09636897251335722
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Municipal Natural Science Foundation
- National Key Research and Development Program of China